List of Excipients in API SEBETRALSTAT
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing SEBETRALSTAT
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals Ltd | EKTERLY | sebetralstat | 82928-300 | CROSCARMELLOSE SODIUM | 2030-07-03 |
| KalVista Pharmaceuticals Ltd | EKTERLY | sebetralstat | 82928-300 | FERRIC OXIDE YELLOW | 2030-07-03 |
| KalVista Pharmaceuticals Ltd | EKTERLY | sebetralstat | 82928-300 | FERROSOFERRIC OXIDE | 2030-07-03 |
| KalVista Pharmaceuticals Ltd | EKTERLY | sebetralstat | 82928-300 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | 2030-07-03 |
| KalVista Pharmaceuticals Ltd | EKTERLY | sebetralstat | 82928-300 | GUAR GUM | 2030-07-03 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for SEBETRALSTAT
Excipient focus: CROSCARMELLOSE SODIUM
SEBETRALSTAT drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
SEBETRALSTAT drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
SEBETRALSTAT drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
SEBETRALSTAT drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GUAR GUM
SEBETRALSTAT drug variants containing GUAR GUM
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing GUAR GUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
SEBETRALSTAT drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
SEBETRALSTAT drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
SEBETRALSTAT drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
SEBETRALSTAT drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
SEBETRALSTAT drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
SEBETRALSTAT drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
SEBETRALSTAT drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
SEBETRALSTAT drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
SEBETRALSTAT drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
SEBETRALSTAT drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| KalVista Pharmaceuticals Ltd | sebetralstat | 82928-300 |
| >Company | >Ingredient | >NDC |
SEBETRALSTAT drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch